Skip to main content
Clinical Trials/NL-OMON23738
NL-OMON23738
Completed
Not Applicable

Management of Atrial fibriLLation INcluding tailoring of anticoagulation in patients from primary care

Sponsor (verrichter) is the Isala hospital, Zwolle, the Netherlands. Performer (uitvoerder) is the Julius Center for Health Sciences and Primary Care of the University Medical Center Utrecht, The Netherlands.0 sites1,000 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial fibrillation, anticoagulation, comorbidity, integrated care, primary care. Atriumfibrilleren, antistolling, comorbiditeit, integrale zorg, eerste lijn.
Sponsor
Sponsor (verrichter) is the Isala hospital, Zwolle, the Netherlands. Performer (uitvoerder) is the Julius Center for Health Sciences and Primary Care of the University Medical Center Utrecht, The Netherlands.
Enrollment
1000
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Sponsor (verrichter) is the Isala hospital, Zwolle, the Netherlands. Performer (uitvoerder) is the Julius Center for Health Sciences and Primary Care of the University Medical Center Utrecht, The Netherlands.

Eligibility Criteria

Inclusion Criteria

  • Participating primary care practices need to be willing and able to provide integral management to their AF patients.
  • Patients aged 65 years or over of participating practices with documented AF are eligible for participation if they do not meet any of the exclusion criteria.

Exclusion Criteria

  • Unwillingness to provide informed consent by the participating general practitioners is the only exclusion criterion for primary care practices in this study.
  • Patients are not eligible for this study if
  • a) they have a life expectancy shorter than 3 months,

Outcomes

Primary Outcomes

Not specified

Similar Trials